The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders [Paperback]
Author: Elaine A. Moore | Language: English | ISBN: 0786437154 | Format: PDF, EPUB
The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
Download books file now The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders for everyone book mediafire, rapishare, and mirror link
Download books file now The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders for everyone book mediafire, rapishare, and mirror link
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.
Books with free ebook downloads available The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders - Paperback: 223 pages
- Publisher: McFarland (December 1, 2008)
- Language: English
- ISBN-10: 0786437154
- ISBN-13: 978-0786437153
- Product Dimensions: 8.8 x 5.9 x 0.7 inches
- Shipping Weight: 9.6 ounces (View shipping rates and policies)
- Amazon Best Sellers Rank: #120,207 in Books (See Top 100 in Books)
- #23 in Books > Health, Fitness & Dieting > Diseases & Physical Ailments > Multiple Sclerosis
Elaine Moore and Samantha Wilkinson's (Sammy Jo) book on `Low Dose Naltrexone Therapy' is a much needed book. LDN therapy is an off-label use of an established, FDA approved drug - Naltrexone -- used to help modulate the immune system for autoimmune diseases like MS, Crohn's, and others. However, LDN therapy has also been proven beneficial for cancers by helping to reduce tumor size - in pancreatic cancer for example. The dose of Naltrexone used in LDN therapy is similar to the doses that are used in homeopathic medicines. It's good to have a reference that cites credible professionals describing the safety and efficacy of this therapy.
The information about LDN therapy is presented so that the average person (non medical) can understand the history behind LDN therapy, how LDN therapy works, and offer guidelines to help a patient talk to their doctor about the applicability of LDN therapy for their own health issues. I particularly liked how the writers broke chapters into smaller sections with clear, descriptive headings -- really made for easy reading even though some of the information is very technical.
There are a number of resources included in the book as well as a glossary and index. Specific conditions are also covered - like `autism' for example. Also, information about clinical trials is included. I especially found Sammy Jo's experience with MS and LDN to be very inspiring.
I particularly liked that the writers highlighted that the older theories of autoimmune disease proposed that the immune system was `hyperactive, strong, and easily stimulated'. Whereas new theories accept that the immune system in autoimmune disease is in-fact ` weak and ineffective'.
No comments:
Post a Comment